Legis Daily

Medicare Prescription Drug Price Negotiation Act of 2021

USA117th CongressHR-2071| House 
| Updated: 3/19/2021
Peter Welch

Peter Welch

Democratic Representative

Vermont

Cosponsors (12)
Ruben Gallego (Democratic)Raúl M. Grijalva (Democratic)Mark Pocan (Democratic)David N. Cicilline (Democratic)Raul Ruiz (Democratic)Carolyn B. Maloney (Democratic)Stephen F. Lynch (Democratic)Kathy Castor (Democratic)Betty McCollum (Democratic)Adam Smith (Democratic)Debbie Wasserman Schultz (Democratic)Chellie Pingree (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medicare Prescription Drug Price Negotiation Act of 2021 This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-448
Medicare Drug Price Negotiation Act

Bill from Previous Congress

HR 116-275
Medicare Prescription Drug Price Negotiation Act of 2019
Mar 18, 2021
Introduced in House
Mar 18, 2021
Referred to the Subcommittee on Health.
Mar 18, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 19, 2021
Referred to the Subcommittee on Health.
Mar 23, 2021

Latest Companion Bill Action

S 117-908
Introduced in Senate
  • Bill from Previous Congress

    HR 116-448
    Medicare Drug Price Negotiation Act


  • Bill from Previous Congress

    HR 116-275
    Medicare Prescription Drug Price Negotiation Act of 2019


  • March 18, 2021
    Introduced in House


  • March 18, 2021
    Referred to the Subcommittee on Health.


  • March 18, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • March 19, 2021
    Referred to the Subcommittee on Health.


  • March 23, 2021

    Latest Companion Bill Action

    S 117-908
    Introduced in Senate

Health

Related Bills

  • HR 117-2881: Medicare Buy-In and Health Care Stabilization Act of 2021
Health care costs and insuranceInflation and pricesMedicarePrescription drugsPublic contracts and procurement

Medicare Prescription Drug Price Negotiation Act of 2021

USA117th CongressHR-2071| House 
| Updated: 3/19/2021
Medicare Prescription Drug Price Negotiation Act of 2021 This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-448
Medicare Drug Price Negotiation Act

Bill from Previous Congress

HR 116-275
Medicare Prescription Drug Price Negotiation Act of 2019
Mar 18, 2021
Introduced in House
Mar 18, 2021
Referred to the Subcommittee on Health.
Mar 18, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 19, 2021
Referred to the Subcommittee on Health.
Mar 23, 2021

Latest Companion Bill Action

S 117-908
Introduced in Senate
  • Bill from Previous Congress

    HR 116-448
    Medicare Drug Price Negotiation Act


  • Bill from Previous Congress

    HR 116-275
    Medicare Prescription Drug Price Negotiation Act of 2019


  • March 18, 2021
    Introduced in House


  • March 18, 2021
    Referred to the Subcommittee on Health.


  • March 18, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • March 19, 2021
    Referred to the Subcommittee on Health.


  • March 23, 2021

    Latest Companion Bill Action

    S 117-908
    Introduced in Senate
Peter Welch

Peter Welch

Democratic Representative

Vermont

Cosponsors (12)
Ruben Gallego (Democratic)Raúl M. Grijalva (Democratic)Mark Pocan (Democratic)David N. Cicilline (Democratic)Raul Ruiz (Democratic)Carolyn B. Maloney (Democratic)Stephen F. Lynch (Democratic)Kathy Castor (Democratic)Betty McCollum (Democratic)Adam Smith (Democratic)Debbie Wasserman Schultz (Democratic)Chellie Pingree (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 117-2881: Medicare Buy-In and Health Care Stabilization Act of 2021
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Health care costs and insuranceInflation and pricesMedicarePrescription drugsPublic contracts and procurement